Home Privacy Archive Realtime Report

Stock Trading History of Saunders Michael E

The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Saunders Michael E since year 2005. The trader's CIK number is 1308926. At the time of this reporting, Saunders Michael E is the VP, Clinical Development of Allos Therapeutics Inc (stock ticker symbol ALTH).

Stock purchases, sales, and option exercises reported by *Saunders Michael E* since 2005.
Trade Date	Symbol	Company Name (Issuer)	Trade Type	Shares	Price ($)	Value ($)
2006-12-29	ALTH	Allos Therapeutics Inc	Purchase	2,500	1.82	4,547

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Saunders Michael E (VP, Clinical Development of Allos Therapeutics Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.